BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 33126517)

  • 1. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks.
    Sharma M; Pruitt K
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling pathway in cancer immunotherapy.
    Zhou Y; Xu J; Luo H; Meng X; Chen M; Zhu D
    Cancer Lett; 2022 Jan; 525():84-96. PubMed ID: 34740608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/Planar Cell Polarity Signaling: New Opportunities for Cancer Treatment.
    Daulat AM; Borg JP
    Trends Cancer; 2017 Feb; 3(2):113-125. PubMed ID: 28718442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt signaling pathway: a potential therapeutic target against cancer.
    Ghosh N; Hossain U; Mandal A; Sil PC
    Ann N Y Acad Sci; 2019 May; 1443(1):54-74. PubMed ID: 31017675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies.
    Yang K; Wang X; Zhang H; Wang Z; Nan G; Li Y; Zhang F; Mohammed MK; Haydon RC; Luu HH; Bi Y; He TC
    Lab Invest; 2016 Feb; 96(2):116-36. PubMed ID: 26618721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs.
    Yang X; Cao D; Ma W; Gao S; Wen G; Zhong J
    Life Sci; 2022 Jul; 300():120565. PubMed ID: 35461838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.
    Mohammed MK; Shao C; Wang J; Wei Q; Wang X; Collier Z; Tang S; Liu H; Zhang F; Huang J; Guo D; Lu M; Liu F; Liu J; Ma C; Shi LL; Athiviraham A; He TC; Lee MJ
    Genes Dis; 2016 Mar; 3(1):11-40. PubMed ID: 27077077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of noncanonical Wnt signaling in cancers.
    Chen Y; Chen Z; Tang Y; Xiao Q
    Biomed Pharmacother; 2021 Jan; 133():110946. PubMed ID: 33212376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling in cancer.
    Zhan T; Rindtorff N; Boutros M
    Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling in development and tissue homeostasis.
    Steinhart Z; Angers S
    Development; 2018 Jun; 145(11):. PubMed ID: 29884654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.
    Harb J; Lin PJ; Hao J
    Curr Oncol Rep; 2019 Feb; 21(2):12. PubMed ID: 30715618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt Signaling: Paths for Cancer Progression.
    Carreira-Barbosa F; Nunes SC
    Adv Exp Med Biol; 2020; 1219():189-202. PubMed ID: 32130700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt pathway: emerging anticancer strategies.
    Gupta A; Verma A; Mishra AK; Wadhwa G; Sharma SK; Jain CK
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):138-47. PubMed ID: 23432158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
    Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
    BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders.
    Caspi M; Wittenstein A; Kazelnik M; Shor-Nareznoy Y; Rosin-Arbesfeld R
    Adv Drug Deliv Rev; 2021 Feb; 169():118-136. PubMed ID: 33346022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling.
    Huang TS; Li L; Moalim-Nour L; Jia D; Bai J; Yao Z; Bennett SA; Figeys D; Wang L
    Stem Cells; 2015 May; 33(5):1419-33. PubMed ID: 25538040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.
    Tabatabai R; Linhares Y; Bolos D; Mita M; Mita A
    Target Oncol; 2017 Oct; 12(5):623-641. PubMed ID: 28653295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we safely target the WNT pathway?
    Kahn M
    Nat Rev Drug Discov; 2014 Jul; 13(7):513-32. PubMed ID: 24981364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt signaling pathway in cancer.
    Duchartre Y; Kim YM; Kahn M
    Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.